Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

7.0%

18 terminated/withdrawn out of 258 trials

Success Rate

90.3%

+3.7% vs industry average

Late-Stage Pipeline

3%

8 trials in Phase 3/4

Results Transparency

29%

48 of 168 completed trials have results

Key Signals

31 recruiting48 with results11 terminated7 withdrawn

Enrollment Performance

Analytics

N/A
174(79.8%)
Phase 2
22(10.1%)
Phase 1
8(3.7%)
Early Phase 1
6(2.8%)
Phase 3
5(2.3%)
Phase 4
3(1.4%)
218Total
N/A(174)
Phase 2(22)
Phase 1(8)
Early Phase 1(6)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (258)

Showing 20 of 258 trials
NCT05456841Not ApplicableRecruiting

Empathic Communication Skills (ECS) Training

Role: collaborator

NCT07265739Phase 2Not Yet Recruiting

Losartan and Paclitaxel in Platinum Resistant Ovarian Cancer

Role: collaborator

NCT06202183Not ApplicableRecruiting

Exercise for Gut Microbiome in Patients With Young-Onset Colorectal Cancer Undergoing Chemotherapy: The COURAGE Trial

Role: collaborator

NCT07795801Not ApplicableNot Yet Recruiting

Mind-Body Sexual Well-Being Program for Female GI Cancer Survivors

Role: collaborator

NCT04409236Not ApplicableActive Not Recruiting

Quit2Heal Smartphone App in Helping Cancer Patients Quit Smoking

Role: collaborator

NCT06934642Early Phase 1Recruiting

Effect of Tirzepatide on Markers of MASLD in Patients With Obesity

Role: collaborator

NCT01410942Phase 2Active Not Recruiting

Multimodal Therapy for the Treatment of Fatigue in Patients With Prostate Cancer Receiving Radiotherapy With Androgen Deprivation Therapy

Role: collaborator

NCT05407168Not ApplicableActive Not Recruiting

Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation Tool

Role: collaborator

NCT05500092Phase 2Active Not Recruiting

An Open Label, Randomized Study of Neoadjuvant Nivolumab and Chemotherapy, With or Without Sub-ablative Stereotactic Body Radiation Therapy, for Resectable Stage IIA to IIIB Non-small Cell Lung Cancer

Role: collaborator

NCT07139769Not ApplicableRecruiting

Adapting Psychosocial Resiliency Intervention for Parents of Adolescents and Young Adults With Cancer

Role: collaborator

NCT07539649Not ApplicableNot Yet Recruiting

LiveWell mBc: Adapted Dialectical Behavioral Therapy Skills Training

Role: collaborator

NCT06671730Not ApplicableCompleted

Self-Determination Theory-informed Occupational Therapy Program to Increase Physical Activity Among Survivors of Breast Cancer

Role: collaborator

NCT07160933Not ApplicableNot Yet Recruiting

Development of a Psychosocial Intervention to Reduce Post Traumatic Stress in Young Adult Survivors of Cancer

Role: collaborator

NCT06728072Phase 2Recruiting

Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer

Role: collaborator

NCT05904782Recruiting

Development of Brief Positive Affect Treatment (PAT) for Caregivers of Patients With Advanced Cancer

Role: collaborator

NCT07761988Not ApplicableNot Yet Recruiting

The FamilyStrong Pilot Randomized Trial

Role: collaborator

NCT07454330Not ApplicableRecruiting

Study of a Support Program for Quality of Life in Chinese Cancer Patients and Survivors

Role: collaborator

NCT05364372Not ApplicableCompleted

SMLI With Hispanic Cancer Survivors and Caregivers

Role: collaborator

NCT07728773Not ApplicableNot Yet Recruiting

A Stepped Intervention for Coping With Dyspnea in Patients With Lung Cancer-Phase A (Open Pilot)

Role: collaborator

NCT03384134Not ApplicableCompleted

Treating Pain in Children With Cancer: Pain Buddy

Role: collaborator